American Association for Cancer Research

2007 AACR Annual Meeting Minority Scholars

Victor D. Acevedo, B.S., Baylor College of Medicine, Houston, TX.  Abstract #3059.  Conditional activation of FGF Receptor-1 leads to an irreversible prostate adenocarcinoma and allows for an epithelial to mesenchymal transition.

Guillermo N. Armaiz-Pena, B.S., UT M. D. Anderson Cancer Center, Houston, TX. Abstract #5495.  Estrous cycle modulates ovarian cancer growth.

Gabriela Andrea Balogh, Ph.D., Fox Chase Cancer Center, Philadelphia, PA. Abstract #1672.  Identification of a unique genomic signature induced by early pregnancy in the human breast of postmenopausal women.

Omari J. Bandele, B.S., Vanderbilt Univ. School of Medicine, Nashville, TN. Abstract #769.  Bioflavonoids as poisons of human topoisomerase alpha and beta.

Melanie C. Bocanegra, B.S., Stanford University School of Medicine, Stanford, CA.  Abstract #4431.  Functional dissection of the 11q14 amplicon in breast cancer implicates GAB2 as a driver oncogene.

Chastity Bradley, M.S., Vanderbilt University Medical Center, Nashville, TN. Abstract #1152.  Carcinogen-induced histone alteration in normal human mammary epithelial cells.

Joann Brooks, Ph.D., Emory University/Winship Cancer Institute, Atlanta, GA. Abstract #2097.  CXCR4/SDF-1 axis regulates HIF-1 mediated VEGF expression.

Vernon T. Cannon, M.D., Ph.D., Evanston Northwestern Healthcare, Evanston, IL. Abstract #2589.  Eicosanoids of the omega-3 fatty acid family inhibit proliferation of normal and malignant ovarian epithelial cells compared to omega-6 fatty acids: The importance of diet modification for chemoprevention.

David J. Castro, B.S., Oregon State University, Corvallis, OR. Abstract #4210The role of caffeine and epigallocatechin-3-gallate in green tea, added to maternal drinking water, on chemoprevention of transplacental cancer induced by dibenzo [a,l] pyrene (DBP).

Miquella G. Chavez, B.S., University of New Mexico, Albuquerque, NM. Abstract #2045.  Dynamics of cell-cell junctions in squamous cell carcinoma.

Karen D. Cowden Dahl, Ph.D., University of New Mexico, Albuquerque, NM. Abstract #3074.  PEA3 transcriptionally activates both MMP-9 and MMP-14 in response to EGF signaling in ovarian tumor cells.

Anatasha C. Crawford, B.S., Georgetown University, Washington, DC. Abstract #3623The role of Bcl-2 in antiestrogen resistant breast cancer cells.

Roberto Diaz, M.D., Ph.D., Vanderbilt University Medical Center, Nashville, TN. Abstract #4657.  Recombinant peptides as biomarkers for cancer response to tyrosine kinase inhibitors combined with radiation.

Katerina D. Fagan-Solis, B.S., University of Massachusetts, Amherst, MA. Abstract #5208.  The role of SKP2 in the proliferative and aggressive nature of estrogen receptor negative breast cancer.

Chantel F. Fuqua, B.S., Meharry Medical College, Nashville, TN. Abstract #4461.  IL-21 stimulates activation of STAT proteins including STAT2/4/6 and regulates cytokine and chemokine expression in human U937 leukemia cells.

Willietta Gibson, B.S., Medical University of South Carolina, Charleston, SC. Abstract #2115.  PAX2 oncogene regulates human beta defensin-1 expression and mediated cell death in prostate cancer cell lines.

Hisani N. Horne, B.S., Duke University, Durham, NC. Abstract #1042.  Hypermethylation of the MAL gene promoter in breast cancer.

Nikia A. Laurie, Ph.D., St. Jude Children's Research Hospital, Memphis, TN. Abstract #5564.  Targeting the secondary mutation in retinoblastoma.

Catherine R. Lewis, B.S., Morehouse School of Medicine, Atlanta, GA. Abstract #4532.  Structural and functional analysis of BRCA1 isoforms.

Claudia P. Miller, M.S., UT M.D. Anderson Cancer Center, Houston, TX. Abstract #2486.  The novel proteasome inhibitor, NPI-0052, synergizes with HDAC inhibitors to trigger apoptosis in leukemia cells.

John K. Smith, B.S., University of Mississippi Medical Center, Jackson, MS. Abstract #2392.  Identification of redox-regulatory cysteine residues in the catalytic domain of Janus kinase 2.

Jeanine A. Southerland, B.S., Winship Cancer Institute - Emory University, Atlanta, GA.  Abstract #1310.  CXCR4 and ABCG2 as cell surface biomarkers for poorly differentiated cancer stem cell population.

Shana J. Sturla, Ph.D., University of Minnesota, Minneapolis, MN. Abstract #1392.  Investigating the mechanism of selective toxicity of antitumor acylfulvenes: Identification of depurinating acylfulvene-DNA adducts.

Brooke E. Sylvester, B.S., University of Chicago, Chicago, IL. Abstract #199.  Disparities in colorectal cancer: Retrospective analysis of mismatch repair genes and molecular targets.

Gabriel J. Villares, B.S., UT M. D. Anderson Cancer Center, Houston, TX. Abstract #4713.   Identification of novel metastasis-related signaling pathways in human melanoma following PAR-1 knockdown by lentiviral based siRNA.